MLANA Antikörper
Kurzübersicht für MLANA Antikörper (ABIN3025225)
Target
Alle MLANA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Verwendungszweck
- Anti-Melan-A Antibody (azide and preservative free)
-
Keine Kreuzreaktivität
- Maus, Ratte (Rattus)
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- Recombinant human protein was used as the immunogen for this anti-Melan-A antibody.
-
Isotyp
- IgG2b, lambda
-
-
-
-
Applikationshinweise
-
The optimal dilution of the anti-Melan-A antibody for each application should be determined by the researcher.
1. Staining of formalin-fixed tissues is enhanced by boiling tissue sections in pH 9 10 mM Tris with 1 mM EDTA for 10-20 min followed by cooling at RT for 20 minutes.
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the anti-Melan-A antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- MLANA (Melan A (MLANA))
-
Andere Bezeichnung
- Melan-A
-
Hintergrund
- Melan-A/MART-1 is a melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Seven other melanoma associated antigens recognized by autologous cytotoxic T cells include MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1/Melan-A is present in melanosomes and endoplasmic reticulum. This mAb labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. It does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.
-
UniProt
- Q16655
Target
-